BrainsWay

BrainsWay

Medical Equipment Manufacturing

Burlington, MA 22,780 followers

Global leader in advanced noninvasive neurostimulation treatments for mental health disorders.

About us

BrainsWay is a global leader in advanced noninvasive neurostimulation treatments for mental health disorders. The Company is boldly advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS™) platform technology to improve health and transform lives. BrainsWay is the first and only TMS company to obtain three FDA-cleared indications backed by pivotal studies demonstrating clinically proven efficacy. Current indications include major depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. The Company is dedicated to leading through superior science and building on its unparalleled body of clinical evidence. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. Founded in 2003, with offices in Burlington, MA and Jerusalem, Israel, BrainsWay is committed to increasing global awareness of and broad access to Deep TMS. For the latest news and information about BrainsWay, please visit www.brainsway.com.

Industry
Medical Equipment Manufacturing
Company size
51-200 employees
Headquarters
Burlington, MA
Type
Public Company
Founded
2003
Specialties
Deep TMS (Transcranial Magnetic Stimluation), Brain Disorder Treatment, Medical Devices, neuromodulation, mental health, Brain, Neurology, Depression, Obsessive-Compulsive Disorder, Anxious Depression, and Smoking Addiction

Locations

Employees at BrainsWay

Updates

Similar pages

Browse jobs

Funding

BrainsWay 5 total rounds

Last Round

Post IPO equity

US$ 20.0M

See more info on crunchbase